Invention Grant
- Patent Title: Modified interleukin-7 protein
-
Application No.: US15126313Application Date: 2016-06-10
-
Publication No.: US10208099B2Publication Date: 2019-02-19
- Inventor: Se Hwan Yang , Donghoon Choi , Hye Seong Lim
- Applicant: Genexine, Inc.
- Applicant Address: KR Seongnam-si
- Assignee: GENEXINE, INC.
- Current Assignee: GENEXINE, INC.
- Current Assignee Address: KR Seongnam-si
- Agency: Sughrue Mion, PLLC
- Priority: KR10-2015-0082793 20150611
- International Application: PCT/KR2016/006214 WO 20160610
- International Announcement: WO2016/200219 WO 20161215
- Main IPC: C07K14/54
- IPC: C07K14/54 ; A61K38/20 ; A61K38/00
Abstract:
The present invention provides a modified interleukin-7 and a use thereof. The modified IL-7 or an IL-7 fusion protein of the present invention comprising the same can be obtained in high yield, and biologically active in viral infection and cancer models. Therefore, they can be used for the prevention and treatment of various diseases.
Public/Granted literature
- US20170158746A1 MODIFIED INTERLEUKIN-7 PROTEIN AND USES THEREOF Public/Granted day:2017-06-08
Information query
